Vertex Pharmaceuticals

These Mutated Cystic Fibrosis Cells Are Worth Billions to Vertex Pharma

These Mutated Cystic Fibrosis Cells Are Worth Billions to Vertex Pharma

TheStreet.com

Vertex's Roadmap to $10 Billion in Cystic Fibrosis Drug Sales

Vertex's Roadmap to $10 Billion in Cystic Fibrosis Drug Sales

TheStreet.com

[video] Biotech's Next Big Thing: Vertex

[video] Biotech's Next Big Thing: Vertex

TheStreet.com

Remember Vertex? Important Cystic Fibrosis Data On Tap Next Week

Remember Vertex? Important Cystic Fibrosis Data On Tap Next Week

TheStreet.com

Drugs Go From Hit to Dud in Two Years in Hepatitis Race

Drugs Go From Hit to Dud in Two Years in Hepatitis Race

Bloomberg

The Race For Oral HCV?

The Race For Oral HCV?

Seeking Alpha

A Non-Profit, A Vertex Drug And Conflicts Of Interest

A Non-Profit, A Vertex Drug And Conflicts Of Interest

Pharmalot

Racing Toward the Next Hepatitis C Drug Approval

Racing Toward the Next Hepatitis C Drug Approval

Motley Fool

Vertex Pharmaceuticals: Today's Featured Drugs Laggard

Vertex Pharmaceuticals: Today's Featured Drugs Laggard

The Street

Vertex Pharmaceuticals